60 views
1
The company manufactures and markets over 400+ proprietary products developed from over 70 enzymes and probiotics.#

Human Healthcare (75% of revenues)
The company provides proprietary enzyme products and customized enzyme solutions to various pharmaceutical and nutraceutical companies in India, North America, Asia (ex-India), Europe and other countries globally.#

Animal Nutrition (13% of revenues)
It provides enzyme based feed additives for the animal nutrition industry, mainly catering to poultry and swine. Animal Nutrition product offering enables animals to maximize the nutrients they absorb from the feed which helps the customers to reduce the feed costs.#

Industrial Bio-Processing (12% of revenues)
The company produces non-food processing enzymes for various industries such as textiles, leather, detergent and pulp & paper, which are used in the manufacturing of a wide range of products.
It also produces food processing enzymes which are essential for enhancing food and beverage products.#

International Presence
The company is present in more than 45 countries in the world and caters to more than 700 customers worldwide.#
Presently, the company earns 43% of its revenues from India, followed by Americas (42%), Europe (7%) and Rest of world (8%).#

Manufacturing Facilities
The company owns and operates 5 manufacturing facilities in India and 2 in California, USA.# Presently the company has a 480 m³ fermentation capacity from its manufacturing facilities.#

R&D Capabilities
The company operates 5 R&D facilities, 4 in India and 1 in Germany. It has 20+ patents granted to its name till date. It has employed over 100 scientists, microbiologists, engineers, food technologists and biotechnologists.# It has increased its R&D spending from ~3% of turnover in FY18 to ~5% of turnover in FY20.#

Acquisitions
1. JC Biotech Pvt Ltd - In 2016, the company acquired 70% stake in JC Biotech Pvt Ltd for 50 crores. It is a manufacturer of API Serratiopeptidase, an anti-inflammatory enzyme, and has a R&D pipeline of biopharma molecules. It has a production facility in Andhra Pradesh, with a fermentation capacity of 60 m³.# The subsidiary reported a turnover of ~425 crores in FY20.#

2. Evoxx Technologies GmbH - In 2017, the company acquired 100% stake in Evoxx Technologies GmbH for ~55 crores INR . It is an industrial biotech company situated in Germany which is focused on the development & production of industrial enzymes, as well as a few specialized carbohydrates for nutritional applications.#

3. Scitech Specialities Pvt Ltd - In 2020, The company acquired 51% stake in Scitech Specialities Pvt. Ltd for ~31 crores. SSPL specialises in manufacturing effervescent granules and tablets using aqueous granulation technology. The company operates two manufacturing facilities for nutraceuticals and pharmaceuticals, and exports products to several countries including France, Peru, Honduras, Ecuador, Vietnam, Thailand and Turkey.#

Comments